A limited sampling strategy for determining carboplatin AUC and monitoring drug dosage
- 1 January 2000
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 36 (2) , 264-269
- https://doi.org/10.1016/s0959-8049(99)00266-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A limited-sampling method for evaluation of the area under the curve of ultrafilterable carboplatin in childrenCancer Chemotherapy and Pharmacology, 1998
- A single-sample assay for the estimation of the area under the free carboplatin plasma concentration versus time curveCancer Chemotherapy and Pharmacology, 1996
- Comparison of methods for the estimation of carboplatin pharmacokinetics in paediatric cancer patientsEuropean Journal Of Cancer, 1995
- Prediction of Carboplatin Clearance From Standard Morphological and Biological Patient CharacteristicsJNCI Journal of the National Cancer Institute, 1995
- Validation of a limited sampling model for carboplatin in a high-dose chemotherapy combinationCancer Chemotherapy and Pharmacology, 1994
- Escalating High-Dose Carboplatin and Autologous Bone Marrow Transplantation in Solid TumorsOncology, 1993
- Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer.Journal of Clinical Oncology, 1992
- Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors.Journal of Clinical Oncology, 1991
- Carboplatin dosage: prospective evaluation of a simple formula based on renal function.Journal of Clinical Oncology, 1989
- Some suggestions for measuring predictive performanceJournal of Pharmacokinetics and Biopharmaceutics, 1981